ASMB Assembly Biosciences, Inc. - Common Stock
$32.87
가격 · 8월 19, 2026
기준 재무 정보 8월 13, 2026
52주 범위
$20–$40
65% of range
애널리스트 평점
BUY
10 analysts
목표 주가
$50
+52% upside
P/E (TTM)
-59.8
ROE
-5.5%
순이익률
-8.5%
ASMB 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$32.87
시가총액
$521M
P/E (TTM)
-59.8
EPS (TTM)
$-0.55
매출 (TTM)
$72M
배당 수익률
—
ROE
-5.5%
부채/자본
—
52주 범위
$20 – $40
ASMB 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$72M
2016-12-31
→
2025-12-31
EPS
$-0.55
2021-12-31
→
2025-12-31
잉여현금흐름
$-41M
2016-12-31
→
2025-12-31
마진
-8.5%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
ASMB
동종업계 중앙값
P/E (TTM)
-59.8
19.6
P/S (TTM)
7.2
6.4
P/B
2.5
2.6
Price / FCF (주가 / FCF)
-12.7
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
ASMB
동종업계 중앙값
Operating Margin (영업이익률)
-16.8%
—
Net Profit Margin (순이익률)
-8.5%
-104.2%
ROA
-3.2%
-40.3%
ROE
-5.5%
-42.4%
ROIC
-5.9%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
ASMB
동종업계 중앙값
Current Ratio (유동비율)
5.2
5.4
Quick Ratio (당좌 비율)
1.2
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
ASMB
동종업계 중앙값
Revenue YoY (매출 YoY)
153.5%
—
Revenue CAGR 3Y (매출 CAGR 3년)
65.8%
—
Revenue CAGR 5Y (매출 CAGR 5년)
-1.8%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
ASMB
동종업계 중앙값
ASMB 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
10 명의 애널리스트
- 적극 매수 4 40.0%
- 매수 5 50.0%
- 보유 1 10.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
4 명의 애널리스트 · 2026-08-16
중앙값
$47.50
평균
$50.00
← 모든 목표가 하회
$32.87
저가
$43.00
고가
$62.00
중앙값 목표
$47.50
+44.5%
평균 목표
$50.00
+52.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.71%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.54 | $-0.58 | 0.04% |
| 2025년 12월 31일 | $2.48 | $-0.66 | 3.1% |
| 2025년 9월 30일 | $-0.72 | $-0.79 | 0.07% |
| 2025년 6월 30일 | $-1.33 | $-1.39 | 0.06% |
| 2025년 3월 31일 | $-1.17 | $-1.63 | 0.46% |
| 2024년 12월 31일 | $-1.57 | $-2.08 | 0.51% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| EIKN | — | — | — | — | — | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| R&D Expense | $65M | $56M | $49M | $70M | $69M | $107M | $86M | $73M | $44M | $33M | |
| SG&A Expense | $20M | $18M | $23M | $24M | $29M | $37M | $33M | $35M | $17M | $12M | |
| Operating Expenses | $84M | $74M | $72M | $94M | $139M | $144M | $119M | $108M | $61M | · | |
| Operating Income | $-12M | $-45M | $-65M | $-94M | $-133M | $-65M | $-103M | $-93M | $-52M | $-45M | |
| Other Non-op | $6M | $6M | $3M | $1M | $302.0K | $3M | $4M | $3M | $368.0K | $399.0K | |
| Pretax Income | $-6M | $-40M | $-61M | $-93M | $-132M | $-62M | $-98M | $-90M | $-52M | $-45M | |
| Income Tax | $0 | $330.0K | $33.0K | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Net Income | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| EPS (Basic) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| EPS (Diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| Shares (Basic) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| Shares (Diluted) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| EBITDA | $-12M | $-45M | $-64M | $-94M | $-132M | $-64M | $-102M | $-93M | $-52M | $-45M |
대차대조표 25
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $38M | $20M | $52M | $46M | $59M | $47M | $41M | $82M | $29M | |
| Short-term Investments | · | · | · | · | · | · | · | $177M | $38M | $24M | |
| Receivables | $974.0K | $0 | $43.0K | $944.0K | $336.0K | $1M | $3M | $2M | $2M | $0 | |
| Prepaid Expense | $5M | $3M | $3M | $4M | $7M | $7M | $5M | $2M | $898.0K | $611.2K | |
| Current Assets | $255M | $116M | $134M | $97M | $154M | $224M | $283M | $223M | $123M | $54M | |
| PP&E (Net) | $221.0K | $284.0K | $385.0K | $743.0K | $1M | $2M | $2M | $557.0K | $860.0K | $214.7K | |
| PP&E (Gross) | · | · | $595.0K | $2M | $2M | $3M | $3M | $1M | $1M | $409.3K | |
| Accum. Depreciation | · | · | $210.0K | $2M | $1M | $2M | $1M | $1M | $414.0K | $194.6K | |
| Goodwill | · | · | · | · | · | $13M | $13M | $13M | $13M | $13M | |
| Intangibles | · | · | · | · | · | · | · | · | $29M | $29M | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $889.0K | $2M | $6M | $2M | $3M | $340.0K | · | |
| Total Assets | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Accounts Payable | $1M | $585.0K | $461.0K | $2M | $3M | $5M | $2M | $4M | · | · | |
| Accrued Liabilities | $8M | $7M | $6M | $7M | $7M | $12M | $8M | $10M | $6M | $5M | |
| Current Liabilities | $49M | $48M | $39M | $16M | $16M | $24M | $24M | $18M | $13M | $7M | |
| Capital Leases | $2M | $3M | $1M | $101.0K | $3M | $7M | $9M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | $3M | $3M | $3M | · | · | |
| Total Liabilities | $51M | $86M | $96M | $19M | $22M | $43M | $67M | $57M | $56M | $18M | |
| Common Stock | $16.0K | $7.0K | $5.0K | $4.0K | $48.0K | $34.0K | $32.0K | $25.0K | $20.0K | $17.2K | |
| Paid-in Capital | · | · | · | · | · | · | · | $553M | $365M | $289M | |
| Retained Earnings | $-832M | $-826M | $-786M | $-725M | $-631M | $-502M | $-439M | $-342M | $-251M | $-208M | |
| AOCI | $-41.0K | $-211.0K | $-81.0K | $-803.0K | $-419.0K | $-270.0K | $-201.0K | $-347.0K | $-392.0K | $-600.8K | |
| Stockholders' Equity | $207M | $33M | $41M | $83M | $169M | $241M | $273M | $211M | $113M | $80M | |
| Liabilities + Equity | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Shares Outstanding | 15,855,329 | 7,457,240 | 5,482,752 | 4,074,552 | 48,120,437 | 34,026,680 | 32,558,307 | 25,495,425 | 20,137,974 | 17,246,754 |
현금 흐름 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $129.0K | $129.0K | $450.0K | $498.0K | $466.0K | $691.0K | $494.0K | $643.0K | $219.0K | · | |
| Stock-based Comp | $5M | $3M | $5M | $7M | $5M | $22M | $21M | $28M | $9M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Restructuring | · | · | $0 | $1M | $2M | $4M | $2M | · | · | · | |
| Other Non-cash | $-40M | $-14M | $78M | $2M | $33M | $-23M | $-7M | · | · | · | |
| Operating Cash Flow | $-41M | $-51M | $23M | $-84M | $-93M | $-63M | $-84M | $-65M | $2M | $-35M | |
| CapEx | $66.0K | $28.0K | $255.0K | $102.0K | $3M | $470.0K | $2M | $340.0K | $865.0K | $147.0K | |
| Investing Cash Flow | $-113M | $40M | $-69M | $91M | $27M | $68M | $-50M | $-135M | $-16M | $36M | |
| Stock Issued | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | $155M | $65M | · | |
| Net Stock Activity | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | · | · | · | |
| Financing Cash Flow | $175M | $29M | $14M | $614.0K | $53M | $8M | $140M | $160M | $67M | $153.0K | |
| Net Change in Cash | $20M | $19M | $-33M | $7M | $-14M | $13M | $5M | $-41M | $53M | $1M | |
| Taxes Paid | · | $400.0K | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-41M | $-51M | $22M | $-85M | $-96M | $-63M | $-86M | $-65M | $995.5K | $-35M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -16.8% | -159.3% | -902.5% | · | -2121.7% | -81.9% | -643.4% | -626.4% | · | · | |
| Net Margin | -8.5% | -140.9% | -854.8% | · | -2076.3% | -78.6% | -611.6% | -613.0% | · | · | |
| Pretax Margin | -8.5% | -139.7% | -854.3% | · | -2116.8% | -78.6% | -616.5% | -605.6% | · | · | |
| EBITDA Margin | -16.6% | -158.8% | -896.2% | · | -2114.2% | -81.0% | -640.4% | -626.4% | · | · | |
| ROA | -3.2% | -31.4% | -51.3% | -63.6% | -54.8% | -20.0% | -32.1% | -41.5% | -32.0% | -38.2% | |
| ROE | -5.5% | -135.4% | -147.9% | -100.6% | -66.0% | -24.3% | -45.4% | -41.2% | -44.4% | -44.6% | |
| ROIC | -5.9% | -137.3% | -157.4% | -113.9% | -77.0% | · | -37.3% | -44.6% | -38.1% | -55.9% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 | 9.2 | 11.6 | 12.0 | 9.1 | 7.5 | |
| Quick Ratio | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 | 2.5 | 2.1 | 11.9 | 9.1 | 7.4 |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | · | 0.0 | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 148.5 | 1326.5 | 14.5 | · | 8.0 | 34.4 | 5.5 | 6.3 | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 153.5% | 298.2% | · | · | -92.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 65.8% | -55.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| Net Income TTM | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| Market Cap | $539M | $118M | $54M | $763M | $1.35B | $2.47B | $7.99B | $6.92B | $10.93B | $2.51B | |
| P/E | -61.8 | -2.4 | -0.7 | -0.7 | -9.3 | -41.0 | -68.2 | · | · | · | |
| P/S | 7.5 | 4.1 | 7.5 | · | 215.1 | 31.2 | 500.8 | 467.5 | 1212.4 | · | |
| P/B | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.3 | 29.3 | 32.9 | 96.7 | 31.5 | |
| P / Tangible Book | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.8 | · | · | · | · | |
| P / Cash Flow | -13.1 | -2.3 | 2.4 | -9.0 | -14.4 | -39.2 | -95.1 | -106.5 | 5878.7 | -72.1 | |
| P / FCF | -13.1 | -2.3 | 2.4 | -9.0 | -13.9 | -38.9 | -93.4 | -106.0 | 10984.2 | -71.8 | |
| Earnings Yield | -1.6% | -42.4% | -136.0% | -148.0% | -10.7% | -2.4% | -1.5% | · | · | · |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $8M | $42M | $11M | $10M | $9M | $7M | $7M | $9M | $6M | $7M | $0 | $0 | $0 | · | · | |
| R&D Expense | $15M | $15M | $17M | $17M | $16M | $15M | $14M | $14M | $16M | $12M | $11M | $11M | $13M | $15M | $17M | $18M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $9M | $4M | $5M | $5M | $6M | $5M | |
| Operating Expenses | $20M | $20M | $23M | $22M | $21M | $19M | $19M | $18M | $21M | $17M | $20M | $15M | $17M | $20M | $23M | $23M | |
| Operating Income | $-6M | $-11M | $20M | $-11M | $-11M | $-10M | $-12M | $-11M | $-12M | $-11M | $-13M | $-15M | $-17M | $-20M | $-23M | $-23M | |
| Other Non-op | $2M | $2M | $2M | $2M | $895.0K | $1M | $1M | $1M | $1M | $2M | $2M | $628.0K | $592.0K | $609.0K | $583.0K | $256.0K | |
| Pretax Income | · | · | $22M | $-9M | $-10M | · | $-10M | $-10M | $-11M | · | $-11M | $-14M | $-17M | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | · | $-76.0K | $0 | $406.0K | · | $33.0K | $0 | $0 | · | · | · | |
| Net Income | $-4M | $-9M | $22M | $-9M | $-10M | $-9M | $-10M | $-10M | $-11M | $-9M | $-11M | $-14M | $-17M | $-19M | $-22M | $-23M | |
| EPS (Basic) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| EPS (Diluted) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| Shares (Basic) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| Shares (Diluted) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| EBITDA | $-6M | $-11M | · | $-11M | $-11M | $-10M | · | $-11M | $-12M | $-11M | · | $-15M | $-17M | $-19M | · | $-23M |
대차대조표 20
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $31M | $58M | $23M | $24M | $23M | $38M | $28M | $19M | $19M | $20M | $27M | $22M | $43M | $52M | $55M | |
| Receivables | $822.0K | $451.0K | $974.0K | $912.0K | · | · | $0 | $0 | $0 | $43.0K | $43.0K | $0 | $342.0K | $717.0K | $944.0K | $1M | |
| Prepaid Expense | $7M | $6M | $5M | $3M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $5M | |
| Current Assets | $328M | $233M | $255M | $237M | $77M | $96M | $116M | $98M | $113M | $117M | $134M | $50M | $64M | $80M | $97M | $115M | |
| PP&E (Net) | $315.0K | $214.0K | $221.0K | $229.0K | $219.0K | $251.0K | $284.0K | $316.0K | $349.0K | $367.0K | $385.0K | $561.0K | $541.0K | $619.0K | $743.0K | $867.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $552.0K | $332.0K | $334.0K | $889.0K | $2M | |
| Total Assets | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Accounts Payable | $1M | $1M | $1M | $2M | $743.0K | $875.0K | $585.0K | $1M | $801.0K | $727.0K | $461.0K | $758.0K | $904.0K | $1M | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $8M | $6M | $3M | $2M | $7M | $5M | $4M | $2M | $6M | $4M | $4M | $3M | $7M | $6M | |
| Current Liabilities | $23M | $35M | $49M | $53M | $47M | $47M | $48M | $42M | $41M | $39M | $39M | $7M | $9M | $10M | $16M | $15M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $113.0K | $451.0K | $791.0K | $1M | $50.0K | $64.0K | $80.0K | $101.0K | $918.0K | |
| Total Liabilities | $25M | $37M | $51M | $57M | $63M | $72M | $86M | $74M | $81M | $87M | $96M | $10M | $12M | $13M | $19M | $19M | |
| Common Stock | $20.0K | $16.0K | $16.0K | $16.0K | $8.0K | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $53.0K | $52.0K | $52.0K | $4.0K | $48.0K | |
| Retained Earnings | $-845M | $-841M | $-832M | $-854M | $-845M | $-835M | $-826M | $-816M | $-806M | $-795M | $-786M | $-775M | $-760M | $-743M | $-725M | $-702M | |
| AOCI | $-623.0K | $-368.0K | $-41.0K | $-90.0K | $-279.0K | $-253.0K | $-211.0K | $-156.0K | $-293.0K | $-239.0K | $-81.0K | $-275.0K | $-325.0K | $-513.0K | $-803.0K | $-999.0K | |
| Stockholders' Equity | $306M | $199M | $207M | $183M | $18M | $27M | $33M | $26M | $35M | $33M | $41M | $42M | $55M | $70M | $83M | $102M | |
| Liabilities + Equity | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Shares Outstanding | 19,850,342 | 15,892,353 | 15,855,329 | 15,816,987 | 7,672,249 | 7,618,885 | 7,457,240 | 6,354,414 | 6,345,561 | 5,482,752 | 5,482,752 | 52,614,194 | 52,450,731 | 52,015,268 | 4,074,552 | 48,481,194 |
현금 흐름 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20.0K | $26.0K | $32.0K | $32.0K | $32.0K | $33.0K | $32.0K | $33.0K | $32.0K | $32.0K | $84.0K | $116.0K | $126.0K | $124.0K | $124.0K | $134.0K | |
| Stock-based Comp | $2M | $1M | $1M | $2M | $834.0K | $712.0K | $751.0K | $797.0K | $833.0K | $739.0K | $959.0K | $1M | $1M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-700.0K | $800.0K | |
| Other Non-cash | · | $-14M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $14M | $-15M | $-17M | $-23M | $-407.0K | $-15M | $-17M | $-18M | $74M | $-14M | $-14M | $-23M | $-19M | $-20M | |
| CapEx | $0 | $19.0K | $24.0K | $42.0K | $0 | $0 | $0 | $0 | $14.0K | $14.0K | $71.0K | $136.0K | $48.0K | $0 | $0 | $102.0K | |
| Investing Cash Flow | $-92M | $-5M | $21M | $-158M | $17M | $7M | $-7M | $24M | $5M | $17M | $-90M | $19M | $-8M | $10M | $17M | $31M | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $2M | $2M | $0 | $0 | $0 | $0 | $0 | $54.0K | $4M | $325.0K | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $2M | · | · | · | $0 | · | · | · | $4M | · | · | |
| Financing Cash Flow | $109M | $149.0K | $456.0K | $172M | $357.0K | $2M | $17M | $0 | $12M | $0 | $9M | $0 | $134.0K | $4M | $437.0K | $0 | |
| Net Change in Cash | $1M | $-27M | $36M | $-1M | $593.0K | $-15M | $10M | $9M | $459.0K | $-1M | $-7M | $5M | $-22M | $-9M | $-2M | $12M | |
| Free Cash Flow | · | $-22M | · | · | · | $-23M | · | · | · | $-18M | · | · | · | · | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -47.4% | -138.4% | · | -100.9% | -115.2% | -105.5% | · | -160.1% | -143.0% | -185.5% | · | · | · | · | · | · | |
| Net Margin | -28.8% | -110.5% | · | -85.2% | -105.9% | -93.6% | · | -140.4% | -130.7% | -156.9% | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | -85.2% | -105.9% | · | · | -140.4% | -125.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -47.4% | -138.1% | · | -100.9% | -115.2% | -105.2% | · | -160.1% | -143.0% | -184.9% | · | · | · | · | · | · | |
| ROA | -1.9% | -5.4% | · | -5.4% | -10.4% | -8.1% | · | -12.7% | -12.3% | -8.9% | · | -16.7% | -16.1% | -15.4% | · | -12.5% | |
| ROE | -2.4% | -8.0% | · | -8.8% | -38.6% | -29.5% | · | -28.4% | -24.9% | -17.6% | · | -20.0% | -18.9% | -17.5% | · | -14.1% | |
| ROIC | · | · | · | -6.0% | -61.3% | · | · | -42.1% | -36.5% | · | · | · | · | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.0 | 6.6 | · | 4.4 | 1.6 | 2.0 | · | 2.4 | 2.7 | 3.0 | · | 7.0 | 7.3 | 8.0 | · | 7.4 | |
| Quick Ratio | 1.4 | 0.9 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.5 | 0.5 | · | 3.7 | 2.5 | 4.4 | · | 3.6 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | · | · | |
| Receivables Turnover | 32.5 | 33.3 | · | 23.7 | · | · | · | · | 49.9 | 15.2 | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $38M | · | $37M | $34M | $31M | · | $21M | $14M | $6M | · | · | · | · | · | · | |
| Net Income TTM | $-32M | $-37M | · | $-38M | $-40M | $-39M | · | $-44M | $-52M | $-59M | · | $-73M | $-83M | $-90M | · | $-90M | |
| Market Cap | $545M | $441M | · | $405M | $139M | $73M | · | $96M | $87M | $73M | · | $562M | $724M | $524M | · | $954M | |
| P/E | -9.8 | -7.4 | · | -5.4 | -3.0 | -1.5 | · | -1.8 | -1.3 | -1.0 | · | -0.9 | -1.5 | -1.7 | · | -10.5 | |
| P/S | 13.0 | 11.6 | · | 11.0 | 4.0 | 2.4 | · | 4.5 | 6.1 | 12.6 | · | · | · | · | · | · | |
| P/B | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Tangible Book | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Cash Flow | · | -20.0 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | -22.4 | · | · | |
| P / FCF | · | -19.9 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | · | · | · | |
| Earnings Yield | -10.2% | -13.6% | · | -18.5% | -33.1% | -66.1% | · | -55.8% | -78.8% | -99.9% | · | -113.4% | -67.6% | -58.8% | · | -9.6% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $72M | $29M | $7M | $0 | $6M |
| 영업이익률 % | -16.8% | -159.3% | -902.5% | — | -2121.7% |
| 순이익 | $-6M | $-40M | $-61M | $-93M | $-130M |
| 희석 EPS | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 |
| 당좌 비율 | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-41M | $-51M | $22M | $-85M | $-96M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 98개의 제출자 · $481.1M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 40 (+23 이전 분기 대비) | 13 (+4 이전 분기 대비) | 29 (0 이전 분기 대비) | 18 (+4 이전 분기 대비) | +4.9M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $136,770,406 | 4,977,089 | 28.43% | 주식 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $44,094,133 | 1,604,590 | 9.17% | 주식 |
| Paradigm Biocapital Advisors LP | $42,696,995 | 1,553,748 | 8.88% | 주식 |
| Commodore Capital LP | $38,884,200 | 1,415,000 | 8.08% | 주식 |
| RA CAPITAL MANAGEMENT, L.P. | $28,040,867 | 1,020,410 | 5.83% | 주식 |
| JANUS HENDERSON GROUP PLC | $23,479,147 | 849,309 | 4.88% | 주식 |
| Parkman Healthcare Partners LLC | $19,818,054 | 721,181 | 4.12% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $15,359,726 | 558,942 | 3.19% | 주식 |
| Point72 Asset Management, L.P. | $12,657,096 | 460,593 | 2.63% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $8,211,216 | 298,807 | 1.71% | 주식 |
| Schonfeld Strategic Advisors LLC | $6,654,363 | 242,153 | 1.38% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $6,595,964 | 239,963 | 1.37% | 주식 |
| AMERIPRISE FINANCIAL INC | $6,320,400 | 230,000 | 1.31% | 주식 |
| DV EQUITIES, LLC | $6,221,884 | 226,415 | 1.29% | 주식 |
| Aberdeen Group plc | $5,689,652 | 207,047 | 1.18% | 주식 |
| Seven Fleet Capital Management LP | $5,680,995 | 206,732 | 1.18% | 주식 |
| Affinity Asset Advisors, LLC | $5,221,200 | 190,000 | 1.09% | 주식 |
| B Group, Inc. | $4,828,401 | 175,706 | 1.00% | 주식 |
| STATE STREET CORP | $4,724,664 | 171,931 | 0.98% | 주식 |
| STEMPOINT CAPITAL LP | $4,681,987 | 170,378 | 0.97% | 주식 |
| Squadron Capital Management LLC | $4,396,800 | 160,000 | 0.91% | 주식 |
| Woodline Partners LP | $4,143,434 | 150,780 | 0.86% | 주식 |
| Driehaus Capital Management LLC | $4,122,000 | 150,000 | 0.86% | 주식 |
| Ally Bridge Group (NY) LLC | $3,847,200 | 140,000 | 0.80% | 주식 |
| GOLDMAN SACHS GROUP INC | $3,359,155 | 122,240 | 0.70% | 주식 |
| FRANKLIN RESOURCES INC | $3,110,736 | 113,200 | 0.65% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,504,884 | 91,153 | 0.52% | 주식 |
| VANGUARD GROUP INC | $2,269,895 | 66,742 | 0.47% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,032,696 | 73,970 | 0.42% | 주식 |
| HighVista Strategies LLC | $2,017,170 | 73,405 | 0.42% | 주식 |
| Qube Research & Technologies Ltd | $1,414,890 | 51,488 | 0.29% | 주식 |
| MONIMUS CAPITAL MANAGEMENT, LP | $1,307,498 | 47,580 | 0.27% | 주식 |
| Trexquant Investment LP | $1,254,764 | 45,661 | 0.26% | 주식 |
| XTX Topco Ltd | $1,179,387 | 42,918 | 0.25% | 주식 |
| JPMORGAN CHASE & CO | $1,126,389 | 41,780 | 0.23% | 주식 |
| MORGAN STANLEY | $1,116,705 | 40,637 | 0.23% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $1,083,839 | 39,441 | 0.23% | 주식 |
| BlackRock, Inc. | $980,926 | 35,696 | 0.20% | 주식 |
| Squarepoint Ops LLC | $940,201 | 34,214 | 0.20% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $800,437 | 29,128 | 0.17% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $665,098 | 24,203 | 0.14% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $653,062 | 23,765 | 0.14% | 주식 |
| Caption Management, LLC | $627,341 | 22,829 | 0.13% | 주식 |
| ADAR1 Capital Management, LLC | $561,884 | 20,447 | 0.12% | 주식 |
| Palumbo Wealth Management LLC | $545,891 | 19,865 | 0.11% | 주식 |
| CITADEL ADVISORS LLC | $508,380 | 18,500 | 0.11% | 콜 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $502,884 | 18,300 | 0.10% | 풋 옵션 |
| TWO SIGMA INVESTMENTS, LP | $490,738 | 17,858 | 0.10% | 주식 |
| Engineers Gate Manager LP | $488,210 | 17,766 | 0.10% | 주식 |
| Eversept Partners, LP | $453,695 | 16,510 | 0.09% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $415,745 | 15,129 | 0.09% | 주식 |
| Cubist Systematic Strategies, LLC | $413,716 | 16,161 | 0.09% | 주식 |
| Virtus Investment Advisers, LLC | $391,617 | 14,251 | 0.08% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $363,808 | 13,239 | 0.08% | 주식 |
| RHUMBLINE ADVISERS | $318,486 | 11,590 | 0.07% | 주식 |
| Integrated Quantitative Investments LLC | $276,943 | 10,078 | 0.06% | 주식 |
| CITADEL ADVISORS LLC | $271,942 | 9,896 | 0.06% | 주식 |
| DEUTSCHE BANK AG\ | $264,220 | 9,615 | 0.05% | 주식 |
| BANK OF AMERICA CORP /DE/ | $262,901 | 9,567 | 0.05% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $239,076 | 8,700 | 0.05% | 콜 옵션 |
| Bank of New York Mellon Corp | $234,075 | 8,518 | 0.05% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $233,580 | 8,500 | 0.05% | 주식 |
| EntryPoint Capital, LLC | $227,672 | 8,285 | 0.05% | 주식 |
| WELLS FARGO & COMPANY/MN | $226,792 | 8,253 | 0.05% | 주식 |
| Brevan Howard Capital Management LP | $213,382 | 7,765 | 0.04% | 주식 |
| Persistent Asset Partners Ltd | $190,766 | 6,942 | 0.04% | 주식 |
| MetLife Investment Management, LLC | $161,720 | 5,885 | 0.03% | 주식 |
| BARCLAYS PLC | $140,314 | 5,106 | 0.03% | 주식 |
| Vanguard Global Advisers, LLC | $126,820 | 4,615 | 0.03% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $124,182 | 4,519 | 0.03% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $115,416 | 4,200 | 0.02% | 주식 |
| MARSHALL WACE, LLP | $111,184 | 4,046 | 0.02% | 주식 |
| CITIGROUP INC | $109,508 | 3,985 | 0.02% | 주식 |
| Invesco Ltd. | $107,969 | 3,929 | 0.02% | 주식 |
| Nuveen, LLC | $100,824 | 3,669 | 0.02% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $79,884 | 2,907 | 0.02% | 주식 |
| NORTHERN TRUST CORP | $42,512 | 1,547 | 0.01% | 주식 |
| Legal & General Group Plc | $26,326 | 958 | 0.01% | 주식 |
| Ameritas Investment Partners, Inc. | $24,595 | 895 | 0.01% | 주식 |
| Russell Investments Group, Ltd. | $21,654 | 788 | 0.00% | 주식 |
| HSBC HOLDINGS PLC | $17,104 | 16,935 | 0.00% | 주식 |
| Tower Research Capital LLC (TRC) | $14,564 | 530 | 0.00% | 주식 |
| ROYAL BANK OF CANADA | $12,000 | 440 | 0.00% | 주식 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7,145 | 260 | 0.00% | 주식 |
| Accent Capital Management, LLC | $5,826 | 212 | 0.00% | 주식 |
| Sterling Capital Management LLC | $5,469 | 199 | 0.00% | 주식 |
| Truvestments Capital LLC | $5,304 | 193 | 0.00% | 주식 |
| FMR LLC | $4,891 | 178 | 0.00% | 주식 |
| Integrated Wealth Concepts LLC | $2,968 | 108 | 0.00% | 주식 |
| OSAIC HOLDINGS, INC. | $2,748 | 100 | 0.00% | 주식 |
| Quarry LP | $2,061 | 75 | 0.00% | 주식 |
| Caitong International Asset Management Co., Ltd | $2,061 | 75 | 0.00% | 주식 |
| EverSource Wealth Advisors, LLC | $1,511 | 55 | 0.00% | 주식 |
| GSA CAPITAL PARTNERS LLP | $1,180 | 42,931 | 0.00% | 주식 |
| UBS Group AG | $550 | 20 | 0.00% | 주식 |
| Point72 Europe (London) LLP | $332 | 13 | 0.00% | 주식 |
| Allworth Financial LP | $275 | 10 | 0.00% | 주식 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $226 | 8,203 | 0.00% | 주식 |
회사 내부자 34 명의 내부자 · 14 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jason A Okazaki | CEO and President | 2026년 3월 29일 A | 163,354 | 0 | 0 | $0 |
| Samar Michael P. | Chief Financial Officer | 2022년 7월 25일 S | 77,228 | 0 | 0 | $0 |
| Thomas Joseph Russo | CFO | 2021년 3월 29일 A | 54,633 | 0 | 0 | $0 |
| Graham K Cooper | Chief Financial Officer and Chief Operating Officer | 2019년 3월 29일 A | 117,500 | 0 | 0 | $0 |
| Jeanette M Bjorkquist | PFO and PAO | 2026년 6월 17일 S | 14,560 | 0 | 3 | $-9,429 |
| Anuj Gaggar | Chief Medical Officer | 2026년 3월 29일 A | 42,688 | 0 | 0 | $0 |
| Nicole S White | Chief Manufacturing Officer | 2026년 3월 29일 A | 48,145 | 0 | 2 | $-5,257 |
| William E Delaney IV | Chief Scientific Officer | 2026년 3월 29일 A | 60,330 | 0 | 0 | $0 |
| Luisa M Stamm | Chief Medical Officer | 2022년 3월 29일 A | 40,315 | 0 | 0 | $0 |
| Jacqueline Sybil Papkoff | SVP-CSO Microbiome | 2020년 12월 14일 S | 37,364 | 0 | 0 | $0 |
| Richard James Colonno | EVP & CSO, Virology Ops | 2020년 3월 27일 A | 137,009 | 0 | 0 | $0 |
| Uri A Lopatin | Chief Medical Officer | 2019년 3월 29일 A | 627,361 | 0 | 0 | $0 |
| Thomas E Rollins | Chief Development Officer | 2018년 3월 29일 A | 3,750 | 0 | 0 | $0 |
| Thomas Andrew Rowland | Chief Business Officer | 2012년 1월 15일 A | — | 0 | 0 | $0 |
| Michael Houghton | 이사 | 2026년 6월 4일 A | 3,202 | 0 | 0 | $0 |
| Lisa Johnson-Pratt | 이사 | 2026년 6월 4일 A | — | 0 | 0 | $0 |
| John G Mchutchison | 이사 | 2026년 6월 4일 A | 18,347 | 0 | 0 | $0 |
| Gina Consylman | 이사 | 2026년 6월 4일 A | — | 0 | 0 | $0 |
| Susan Mahony | 이사 | 2026년 6월 4일 A | — | 0 | 0 | $0 |
| Anthony E Altig | 이사 | 2026년 6월 4일 A | 40,000 | 0 | 0 | $0 |
| William R Ringo | 이사 | 2025년 6월 5일 A | 17,465 | 0 | 0 | $0 |
| Richard D Dimarchi | 이사 | 2022년 5월 25일 A | — | 0 | 0 | $0 |
| Myron Z Holubiak | 이사 | 2021년 5월 20일 A | — | 0 | 0 | $0 |
| Helen Kim | 이사 | 2020년 6월 11일 A | — | 0 | 0 | $0 |
| Alan Lewis | 이사 | 2020년 6월 11일 A | — | 0 | 0 | $0 |
| Derek A Small | 이사 | 2020년 1월 2일 A | 828,791 | 0 | 0 | $0 |
| Mark Auerbach | 이사 | 2019년 5월 17일 A | — | 0 | 0 | $0 |
| Russell H Ellison | 이사 | 2014년 7월 10일 A | 21,600 | 0 | 0 | $0 |
| Joseph Felder | 이사 | 2013년 3월 6일 A | — | 0 | 0 | $0 |
| Gilead Sciences, Inc. | 10% 소유주 | 2025년 8월 8일 P | 4,505,391 | 0 | 0 | $0 |
| Alexander Schornstein | 10% 소유주 | 2024년 11월 25일 P | 728,113 | 0 | 0 | $0 |
| EcoR1 Capital Fund Qualified, L.P. | 10% 소유주 | 2018년 4월 17일 P | — | 0 | 0 | $0 |
| Adam Zlotnick | 10% 소유주 | 2014년 7월 10일 A | — | 0 | 0 | $0 |
| David Jonathan Barrett | — | 2017년 3월 29일 A | 19,396 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 3 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. ×5 제출 서류 | 2026년 5월 27일 | 25.10% | 수정본 | — | SEC |
| Alexander Schornstein ×3 제출 서류 | 2024년 6월 24일 | — | 최초 제출 | — | SEC |
| 2023년 10월 31일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 12 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.55% | 7,645 NS | 2026년 4월 30일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 9,650 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| IWN · iShares Trust | — | — | 2026년 8월 17일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWC · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026년 7월 13일 | 일간 |
| VHT · VANGUARD WORLD FUND | — | — | 2026년 7월 20일 | 일간 |